News

Published on 5 Apr 2023 on Zacks via Yahoo Finance

Are Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?


Article preview image

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is ASLAN Pharmaceuticals Ltd. (ASLN) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.

ASLAN Pharmaceuticals Ltd. is one of 1154 companies in the Medical group. The Medical group currently sits at #5 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. ASLAN Pharmaceuticals Ltd. is currently sporting a Zacks Rank of #2 (Buy).

NASDAQ.BCEL price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Zymeworks Inc. (NYSE:ZYME) Q4 2023 Earnings Call Transcript

Zymeworks Inc. (NYSE:ZYME) Q4 2023 Earnings Call Transcript March 6, 2024 Zymeworks Inc. beats ea...

Insider Monkey via Yahoo Finance 7 Mar 2024

Zymeworks Inc. (NYSE:ZYME) Q3 2023 Earnings Call Transcript

Zymeworks Inc. (NYSE:ZYME) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good day, ...

Insider Monkey via Yahoo Finance 5 Nov 2023

BAKER BROS. ADVISORS LP Reduces Stake in Atreca Inc

BAKER BROS. ADVISORS LP (Trades, Portfolio), a New York-based private hedge fund sponsor, recentl...

GuruFocus.com via Yahoo Finance 23 Oct 2023

While dollars continue to flow into biotech, companies cut more jobs

A new report plays up the strength of California's life sciences industry. The reality for some B...

American City Business Journals 14 Aug 2023

Atreca (BCEL) Suspends Lead Drug Evaluation, Stock Falls 37%

Atreca, Inc.’s BCEL shares plunged about 37% on Aug 11, 2023, after the company reported structur...

Zacks via Yahoo Finance 14 Aug 2023

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.30% By Investing.com

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.30%

Investing.com 11 Aug 2023

Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In...

Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In...

Investing.com 11 Aug 2023

Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now

Shares of Atreca, Inc. (BCEL) have been struggling lately and have lost 20% over the past week. H...

Zacks via Yahoo Finance 6 Apr 2023

Are Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?

Investors interested in Medical stocks should always be looking to find the best-performing compa...

Zacks via Yahoo Finance 5 Apr 2023

Bill Gates Net Worth, Investments and Holdings

In this article we are going to take a look at an overview of Bill Gates' net worth, his investme...

Insider Monkey via Yahoo Finance 19 Dec 2022